Last Updated: October 17, 2026

CLINICAL TRIALS PROFILE FOR VAMOROLONE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for VAMOROLONE

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02760264 ↗	A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)	Completed	Cooperative International Neuromuscular Research Group	Phase 2	2016-06-01	The purpose of this study is to determine whether a new medication called vamorolone is safe and well-tolerated by boys with Duchenne muscular dystrophy (DMD) ages ≥ 4 and < 7 years old.
NCT02760264 ↗	A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)	Completed	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	Phase 2	2016-06-01	The purpose of this study is to determine whether a new medication called vamorolone is safe and well-tolerated by boys with Duchenne muscular dystrophy (DMD) ages ≥ 4 and < 7 years old.
NCT02760264 ↗	A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)	Completed	National Institute of Neurological Disorders and Stroke (NINDS)	Phase 2	2016-06-01	The purpose of this study is to determine whether a new medication called vamorolone is safe and well-tolerated by boys with Duchenne muscular dystrophy (DMD) ages ≥ 4 and < 7 years old.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for VAMOROLONE

Condition Name

Chart
Table

Condition Name for VAMOROLONE
Intervention	Trials
Duchenne Muscular Dystrophy	6
Becker Muscular Dystrophy	1
Drug Interaction Potentiation	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for VAMOROLONE
Intervention	Trials
Muscular Dystrophy, Duchenne	7
Muscular Dystrophies	6
Ulcer	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for VAMOROLONE

Trials by Country

Map
Table

Trials by Country for VAMOROLONE
Location	Trials
United States	24
United Kingdom	8
Canada	7
Sweden	4
Israel	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for VAMOROLONE
Location	Trials
Texas	4
North Carolina	4
Illinois	4
Florida	4
California	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for VAMOROLONE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for VAMOROLONE
Clinical Trial Phase	Trials
PHASE4	1
PHASE1	2
Phase 2	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for VAMOROLONE
Clinical Trial Phase	Trials
Completed	6
Not yet recruiting	2
RECRUITING	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for VAMOROLONE

Sponsor Name

Chart
Table

Sponsor Name for VAMOROLONE
Sponsor	Trials
ReveraGen BioPharma, Inc.	7
Santhera Pharmaceuticals	5
University of Pittsburgh	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for VAMOROLONE
Sponsor	Trials
Industry	12
Other	10
NIH	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.